[HTML][HTML] Low-dose methotrexate for the prevention of atherosclerotic events
…, E Zaharris, V Mam, A Hasan… - … England Journal of …, 2019 - Mass Medical Soc
Background Inflammation is causally related to atherothrombosis. Treatment with canakinumab,
a monoclonal antibody that inhibits inflammation by neutralizing interleukin-1β, resulted …
a monoclonal antibody that inhibits inflammation by neutralizing interleukin-1β, resulted …
[PDF][PDF] Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we
evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based …
evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based …
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week
Observations on human and experimental atherosclerosis, biomarker studies, and now a
large-scale clinical trial support the operation of immune and inflammatory pathways in this …
large-scale clinical trial support the operation of immune and inflammatory pathways in this …
Ischemia and no obstructive coronary artery disease (INOCA) developing evidence-based therapies and research agenda for the next decade
The Cardiovascular Disease in Women Committee of the American College of Cardiology,
in conjunction with interested parties (from the National Heart, Lung, and Blood Institute, …
in conjunction with interested parties (from the National Heart, Lung, and Blood Institute, …
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis
Background Inflammation plays a fundamental role in atherothrombosis. Yet, whether direct
inhibition of inflammation will reduce the occurrence of adverse cardiovascular outcomes is …
inhibition of inflammation will reduce the occurrence of adverse cardiovascular outcomes is …
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
The RV144 trial demonstrated 31% vaccine efficacy at preventing human immunodeficiency
virus (HIV)-1 infection 1 . Antibodies against the HIV-1 envelope variable loops 1 and 2 (Env …
virus (HIV)-1 infection 1 . Antibodies against the HIV-1 envelope variable loops 1 and 2 (Env …
Effect of genotype-guided oral P2Y12 inhibitor selection vs conventional clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the …
…, C Cagin, L Baudhuin, YP Fu, SG Goodman, A Hasan… - Jama, 2020 - jamanetwork.com
Importance After percutaneous coronary intervention (PCI), patients withCYP2C19*2or*3loss-of-function
(LOF) variants treated with clopidogrel have increased risk of ischemic events. …
(LOF) variants treated with clopidogrel have increased risk of ischemic events. …
Evaluation of phase change materials for thermal regulation enhancement of building integrated photovoltaics
Regulating the temperature of building integrated photovoltaics (BIPV) using phase change
materials (PCMs) reduces the loss of temperature dependent photovoltaic (PV) efficiency. …
materials (PCMs) reduces the loss of temperature dependent photovoltaic (PV) efficiency. …
Time course of LDL cholesterol exposure and cardiovascular disease event risk
Background Incident cardiovascular disease (CVD) increases with increasing low-density
lipoprotein cholesterol (LDL-C) concentration and exposure duration. Area under the LDL-C …
lipoprotein cholesterol (LDL-C) concentration and exposure duration. Area under the LDL-C …
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials
Background. A recombinant canarypox vector expressing human immunodeficiency virus
type 1 (HIV-1) Gag, Pro, and membrane-linked gp120 (vCP1521), combined with a bivalent …
type 1 (HIV-1) Gag, Pro, and membrane-linked gp120 (vCP1521), combined with a bivalent …